[1] 刘玉,周利民,张军. 心率变异性对慢性心力衰竭病情评估及预后的应用价值[J].新疆医科大学学报,2018,41(3):291-294.
[2] BROUX B,CLERCQ D D,VERA L,et al. Can heart rate variability parameters derived by a heart rate monitor differentiate between atrial fibrillation and sinus rhythm?[J].BMC Vet Res,2018,14(1):320.
[3] KIM N H,KIM K H,KO M S. The Effects of an aquatic exercise program on body composition and heart rate variability(HRV) in elderly women with obesity[J].Korean J Sports Sci,2017,26(1):1131-1139.
[4] LI Z J,LU C T,QIU J Y,et al. Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease[J].Int J Clin Exp Pathol,2018,11(3):1620-1628.
[5] 胡大一,孙艺红. 心房颤动的病因和流行病学[J].中国实用内科杂志,2006,26(3):163-164.
[6] 李小鹰. 老年人心房颤动诊治中国专家建议(2011)评介[J].中国实用内科杂志,2012,32(4):894-908.
[7] PABLO D E, SERGIO R R,EMAD A A,et al. Incidence,predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation[J].Int J Cardiol,2020,327(13):217-222.
[8] LEPPNEN M H,HAAPALA E A,VEIJALAINEN A,et al. Associations of cardiometabolic risk factors with heart rate variability in 6-8-year-old children:the PANIC Study[J].Pediatric Diabetes,2019,21(5):251-258.
[9] 余意君,吴师伟,周俊,等. 高血压病患者心率恢复、心率变异性相关指标变化及意义[J].山东医药,2019,59(23):44-46.
[10] 程文波,杨栓锁,杨芹,等. 美多巴对老年血管性帕金森病合并阵发性心房颤动的影响[J].中华老年医学杂志,2018,37(6):646-649.
[11] 徐晓艳,唐啸. HMGB1通过糖基化终末产物受体在动脉粥样硬化发病中的作用[J].临床心血管病杂志,2018,34(9):861-865.
[12] LI X T,GAO L J,WANG Z,et al. Lipid profile and incidence of atrial fibrillation:a prospective cohort study in China[J].Clin Cardiol,2018,41(3):314-320.
[13] 许键,何燕,罗蓓蓓,等. NLRP3炎症小体与心房颤动的相关性研究[J].中国循环杂志,2017,32(1):72-76.
[14] 王昱,陈凯,张继红,等. 慢性肾脏病患者心率变异性的特点及其影响因素分析[J].复旦学报:医学版,2017,44(1):47-52. |
2022, Vol. 39 
